Investment Analysts’ New Coverage for November 13th (ABBV, ADUS, ALXO, AMGN, AVAH, BKV, BMY, BTSG, CERT, CRWV)

Investment Analysts’ new coverage for Thursday, November 13th:

Scotiabank assumed coverage on shares of AbbVie (NYSE:ABBV). They issued a sector outperform rating and a $280.00 target price on the stock.

BMO Capital Markets assumed coverage on shares of Addus HomeCare (NASDAQ:ADUS). They issued a market perform rating and a $120.00 target price on the stock.

Jefferies Financial Group Inc. began coverage on shares of ALX Oncology (NASDAQ:ALXO). They issued a buy rating and a $4.00 price target on the stock.

Scotiabank initiated coverage on shares of Amgen (NASDAQ:AMGN). Scotiabank issued a sector outperform rating and a $385.00 target price on the stock.

BMO Capital Markets assumed coverage on shares of Aveanna Healthcare (NASDAQ:AVAH). The firm issued an outperform rating and a $11.00 price target on the stock.

Barclays PLC assumed coverage on shares of BKV (NYSE:BKV). They issued an overweight rating and a $32.00 price target on the stock.

Scotiabank assumed coverage on shares of Bristol Myers Squibb (NYSE:BMY). The firm issued a sector perform rating and a $45.00 target price on the stock.

BMO Capital Markets started coverage on shares of BrightSpring Health Services (NASDAQ:BTSG). The firm issued an outperform rating and a $40.00 price target on the stock.

BMO Capital Markets assumed coverage on shares of Certara (NASDAQ:CERT). The firm issued a market perform rating and a $9.00 price target on the stock.

Compass Point started coverage on shares of CoreWeave (NASDAQ:CRWV). Compass Point issued a buy rating and a $150.00 target price on the stock.

Leerink Partners initiated coverage on shares of Contineum Therapeutics (NASDAQ:CTNM). The firm issued an outperform rating and a $22.00 price target on the stock.

BMO Capital Markets assumed coverage on shares of Doximity (NASDAQ:DOCS). They issued a market perform rating and a $55.00 target price on the stock.

BMO Capital Markets began coverage on shares of Evolent Health (NYSE:EVH). The firm issued an outperform rating and a $7.00 price target on the stock.

Shore Capital started coverage on shares of WizzFinancial (LON:FIN). They issued a house stock rating on the stock.

Scotiabank assumed coverage on shares of Gilead Sciences (NASDAQ:GILD). They issued a sector outperform rating and a $140.00 price target on the stock.

BMO Capital Markets began coverage on shares of Healthcare Services Group (NASDAQ:HCSG). They issued a market perform rating and a $20.00 price target on the stock.

Scotiabank began coverage on shares of Hecla Mining (NYSE:HL). Scotiabank issued a sector perform rating and a $15.00 price target on the stock.

BMO Capital Markets assumed coverage on shares of HealthEquity (NASDAQ:HQY). The firm issued a market perform rating and a $100.00 target price on the stock.

BMO Capital Markets started coverage on shares of Icon (NASDAQ:ICLR). They issued a market perform rating and a $175.00 target price on the stock.

BMO Capital Markets began coverage on shares of IQVIA (NYSE:IQV). The firm issued an outperform rating and a $260.00 target price on the stock.

Scotiabank assumed coverage on shares of Johnson & Johnson (NYSE:JNJ). Scotiabank issued a sector outperform rating and a $230.00 price target on the stock.

BMO Capital Markets assumed coverage on shares of LifeStance Health Group (NASDAQ:LFST). BMO Capital Markets issued an outperform rating and a $8.00 price target on the stock.

Scotiabank assumed coverage on shares of Eli Lilly and Company (NYSE:LLY). Scotiabank issued a sector outperform rating and a $1,165.00 target price on the stock.

Benchmark Co. initiated coverage on shares of Lifeway Foods (NASDAQ:LWAY). They issued a buy rating and a $35.00 target price on the stock.

BMO Capital Markets assumed coverage on shares of Medpace (NASDAQ:MEDP). BMO Capital Markets issued a market perform rating and a $600.00 price target on the stock.

Leerink Partners started coverage on shares of MannKind (NASDAQ:MNKD). The firm issued an outperform rating and a $7.00 target price on the stock.

Scotiabank began coverage on shares of Merck & Co., Inc. (NYSE:MRK). They issued a sector outperform rating and a $105.00 price target on the stock.

Shore Capital initiated coverage on shares of Marks Electrical Group (LON:MRK). Shore Capital issued a hold rating and a GBX 50 price target on the stock.

BMO Capital Markets began coverage on shares of Omada Health (NASDAQ:OMDA). They issued an outperform rating and a $27.00 price target on the stock.

Jefferies Financial Group Inc. started coverage on shares of Oruka Therapeutics (NASDAQ:ORKA). They issued a buy rating and a $45.00 price target on the stock.

Scotiabank assumed coverage on shares of Pfizer (NYSE:PFE). They issued a sector outperform rating and a $30.00 target price on the stock.

BMO Capital Markets initiated coverage on shares of Phreesia (NYSE:PHR). They issued an outperform rating and a $32.00 price target on the stock.

BMO Capital Markets started coverage on shares of Privia Health Group (NASDAQ:PRVA). The firm issued an outperform rating and a $30.00 price target on the stock.

Canaccord Genuity Group Inc. began coverage on shares of R.E.A. (LON:RE). The firm issued a speculative buy rating and a GBX 260 price target on the stock.

Scotiabank started coverage on shares of Regeneron Pharmaceuticals (NASDAQ:REGN). Scotiabank issued a sector perform rating and a $650.00 target price on the stock.

Oppenheimer Holdings, Inc. initiated coverage on shares of Rocket Companies (NYSE:RKT). They issued an outperform rating and a $25.00 price target on the stock.

BMO Capital Markets started coverage on shares of Sotera Health (NASDAQ:SHC). The firm issued an outperform rating and a $19.00 target price on the stock.

BMO Capital Markets began coverage on shares of TruBridge (NASDAQ:TBRG). The firm issued a market perform rating and a $19.50 target price on the stock.

BMO Capital Markets assumed coverage on shares of Teladoc Health (NYSE:TDOC). BMO Capital Markets issued a market perform rating and a $8.00 price target on the stock.

Leerink Partners started coverage on shares of Trevi Therapeutics (NASDAQ:TRVI). Leerink Partners issued an outperform rating and a $13.00 price target on the stock.

BMO Capital Markets started coverage on shares of Veeva Systems (NYSE:VEEV). They issued a market perform rating and a $300.00 price target on the stock.

Benchmark Co. started coverage on shares of Vital Farms (NASDAQ:VITL). The firm issued a buy rating and a $60.00 price target on the stock.

Scotiabank initiated coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX). The firm issued a sector outperform rating and a $495.00 target price on the stock.

BMO Capital Markets began coverage on shares of Waystar (NASDAQ:WAY). They issued an outperform rating and a $47.00 target price on the stock.